Ursodeoxycholic Acid Tablets IP 300mg URSOGREAT.
Ursodeoxycholic acid prevents post-bariatric gallstones effectively.
24x higher risk of developing cholelithiasis.
ASMBS 2019 guidelines recommends to use atleast 600 mg/d Ursodeoxycholic acid for 6 months after bariatric surgery.
Bariatric patients are prone to gallstone formation, with an alarming overall postoperative risk of 30%-53%.
Among patients with Sleeve Gastrectomy, after 12 months
UDCA group - 5.3% developed gallstones, Non-UDCA users - 88.9% developed gallstones
Dosage & Indications :
For 12 months after sleeve gastrectomy or bypass surgery.
- 300 mg tablets 2-3 times a day.